Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Non-Current Assets (2016 - 2025)

Jaguar Health (JAGX) has disclosed Non-Current Assets for 11 consecutive years, with $20.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 8.03% to $20.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $82.7 million, a 5.66% decrease, with the full-year FY2024 number at $21.2 million, down 6.9% from a year prior.
  • Non-Current Assets was $20.1 million for Q3 2025 at Jaguar Health, down from $20.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $35.2 million in Q3 2021 to a low of $20.1 million in Q3 2025.
  • A 5-year average of $23.9 million and a median of $23.9 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 38.18% in 2021, then decreased 26.02% in 2022.
  • Jaguar Health's Non-Current Assets stood at $24.8 million in 2021, then rose by 1.21% to $25.1 million in 2022, then decreased by 9.28% to $22.8 million in 2023, then dropped by 6.9% to $21.2 million in 2024, then decreased by 5.45% to $20.1 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Non-Current Assets are $20.1 million (Q3 2025), $20.4 million (Q2 2025), and $21.0 million (Q1 2025).